Sept4/ARTS regulates stem cell apoptosis and skin regeneration

Science

Volumn 341, Issue 6143, 2013, Pages 286-289

  Fuchs, Yaron ^a   Brown, Samara ^a   Gorenc, Travis ^a   Rodriguez, Joe ^a   Fuchs, Elaine ^a   Steller, Hermann ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; ETOPOSIDE; SEPTIN; SEPTIN 4; TRANSCRIPTION FACTOR SOX9; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; CANCER; GENETIC STRUCTURE; GENETIC VARIATION; MEDICINE; PHENOTYPE; RODENT;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER CELL; CANCER RISK; CELL COUNT; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FLUORESCENCE ACTIVATED CELL SORTING; GERM CELL; HAIR FOLLICLE; HAIR FOLLICLE STEM CELL; HOMEOSTASIS; KERATINOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGENERATION; REGENERATIVE MEDICINE; RING FINGER MOTIF; SKIN CELL; SKIN INJURY; STEM CELL; WILD TYPE; WOUND HEALING;

MUS;

EID: 84880508697     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1233029     Document Type: Article

References (31)

1. I. L. Weissman, Science 287, 1442-1446 (2000).
2. S. Rafii, D. Lyden, Nat. Med. 9, 702-712 (2003).
3. Y. C. Hsu, E. Fuchs, Nat. Rev. Mol. Cell Biol. 13, 103-114 (2012).
4. Y. Fuchs, H. Steller, Cell 147, 742-758 (2011).
5. M. Gyrd-Hansen, P. Meier, Nat. Rev. Cancer 10, 561-574 (2010).
6. E. Kuranaga, M. Miura, Trends Cell Biol. 17, 135-144 (2007).
7. A. J. Schile, M. García-Fernández, H. Steller, Genes Dev. 22, 2256-2266 (2008).
8. S. Kornbluth, K. White, J. Cell Sci. 118, 1779-1787 (2005).
9. A. Bergmann, A. Y. Yang, M. Srivastava, Curr. Opin. Cell Biol. 15, 717-724 (2003).
10. S. Larisch et al., Nat. Cell Biol. 2, 915-921 (2000).
11. Y. Gottfried, A. Rotem, R. Lotan, H. Steller, S. Larisch, EMBO J. 23, 1627-1635 (2004).
12. M. García-Fernández et al., Genes Dev. 24, 2282-2293 (2010).
13. E. Fuchs, Nature 445, 834-842 (2007).
14. S. J. Morrison, A. C. Spradling, Cell 132, 598-611 (2008).
15. C. A. Jahoda, A. M. Christiano, Cell 146, 678-681 (2011).
16. W. M. Woo, A. E. Oro, Cell 146, 334 (2011).
17. R. J. Morris et al., Nat. Biotechnol. 22, 411-417 (2004).
18. Y. C. Hsu, H. A. Pasolli, E. Fuchs, Cell 144, 92-105 (2011).
19. S. Müller-Röver et al., J. Invest. Dermatol. 117, 3-15 (2001).
20. M. Ito et al., Nat. Med. 11, 1351-1354 (2005).
21. I. Brownell, E. Guevara, C. B. Bai, C. A. Loomis A. L. Joyner, Cell Stem Cell 8, 552-565 (2011).
22. M. Ito et al., Nature 447, 316-320 (2007).
23. J. C. Reed, Cancer Cell 3, 17-22 (2003).
24. E. C. LaCasse et al., Oncogene 27, 6252-6275 (2008).
25. H. Harlin, S. B. Reffey, C. S. Duckett, T. Lindsten C. B. Thompson, Mol. Cell. Biol. 21, 3604-3608 (2001).
26. W. H. Lien et al., Cell Stem Cell 9, 219-232 (2011).
27. J. B. Garrison et al., Mol. Cell 41, 107-116 (2011).
28. N. Edison et al., Cell Death Differ. 19, 356-368 (2012).
29. S. Fulda, D. Vucic, Nat. Rev. Drug Discov. 11, 109-124 (2012).
30. F. Li et al., Sci. Signal. 3, ra13 (2010).
31. A. Bergmann, H. Steller, Sci. Signal. 3, re8 (2010).